missing translation for 'onlineSavingsMsg'
Learn More

ACBD3 Antibody (OTI1G2), DyLight 594, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-72148DL594

Product Code. 18434366

  • € 751.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ACBD3 Monoclonal antibody specifically detects ACBD3 in Human, Mouse, Rat, Canine, Monkey samples. It is validated for Flow Cytometry, Immunohistochemistry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ACBD3
Monoclonal
DyLight 594
acyl-CoA binding domain containing 3, Acyl-CoA-binding domain-containing protein 3, acyl-Coenzyme A binding domain containing 3, GCP60Golgi phosphoprotein 1, GOCAP1Peripheral benzodiazepine receptor-associated protein PAP7, golgi complex associated protein 1, 60kDa, Golgi complex-associated protein 1, Golgi resident protein GCP60, GOLPH1PBR- and PKA-associated protein 7, PAP7, PBR associated protein, peripherial benzodiazepine receptor associated protein, PKA (RIalpha)-associated protein
Full length recombinant protein of human ACBD3 (NP_073572) produced in HEK293T cells.
0.1 mL
Golgi Apparatus Markers
64746
Store at 4°C in the dark.
IgG1
Flow Cytometry, Immunohistochemistry
OTI1G2
50mM Sodium Borate
Mouse
Immunogen affinity purified
RUO
Primary
Human, Mouse, Rat, Canine, Monkey
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.